Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Human thrombin OK’d

This article was originally published in The Gray Sheet

Executive Summary

FDA approves the biologics license application for Evithrom, a protein that helps control bleeding during surgery, Aug. 27. Evithrom, manufactured by Omrix Biopharmaceuticals and marketed by Johnson & Johnson/Ethicon, is the first human thrombin approved since 1954, and will be the only such product on the market, according to FDA. Derived from human plasma from U.S. donors, human thrombin may prevent the immunogenic response some patients have to bovine-derived thrombin. Ethicon will market Evithrom both as a standalone thrombin and in conjunction with the absorbable gel sponge Surgiflo hemostatic matrix with FlexTip...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT025204

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel